|
End-of-day quote
Other stock markets
|
||
| - USD | - |
|
| 2015 | AstraZeneca : Three months on, fruitless CEO search overshadows Sanofi | RE |
| 2014 | AstraZeneca : Pfizer's weak drug pipeline fuels hunger for AstraZeneca | RE |
NEW YORK (Reuters) - Shares of Wyeth rose 5.2 percent to $46.00 before the opening bell on Monday after rival Pfizer said it would buy the company for about $68 billion.
The news sent shares of Pfizer, the No. 1 drugmaker, down 3.3 percent at $16.87.
(Reporting by Leah Schnurr; Editing by Theodore d'Afflisio)
| 1st Jan change | Capi. | |
|---|---|---|
| +55.32% | 819B | |
| -6.75% | 351B | |
| +13.56% | 329B | |
| +10.68% | 298B | |
| +16.57% | 242B | |
| +2.04% | 225B | |
| +13.31% | 217B | |
| +8.48% | 168B | |
| -2.81% | 158B |
WYETH LLC 
By 
